title: [The use of methylphenidate in children: analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions].
abstract: In Germany only few data is available on the use of stimulants in the treatment of Attention Deficit/Hyperactivity Disorder. For the first time a full survey of health insurance data was carried out on methylphenidate prescriptions from 2000 to 2001 in an East German District. 783 patients of the total cohort received at least one prescription for methylphenidate. In our sample, the treatment prevalence more than doubled in the observation period from 0.6 % to 1.4 % in children aged between 5 and 15 years, this age group representing the largest treatment group. Younger children, adolescents and adults were only rarely treated. The treatment was undertaken predominantly by paediatricians, general practitioners and neurologists/psychiatrists/child psychiatrists. Prescriptions were issued by one, or by not more than two doctors.
  
  
  CONCLUSIONS
  In Mecklenburg-Vorpommern the prevalence of stimulant treatment has clearly increased. Since diagnosis-related data is not available it is not possible to assess the indications for treatment. Further studies should serve to evaluate the correspondence between diagnosis and therapy in relation to stimulant medication.
authors.affiliation: Gerhard-Kienle-Lehrstuhl für Medizintheorie und Komplementärmedizin, Fakultät für Medizin, Universität Witten/Herdecke. S.Schmidt-Troschke@gemeinschaftskrankenhaus.de
authors.forename: S O
authors.initials: SO
authors.lastname: Schmidt-Troschke
authors.forename: T
authors.initials: T
authors.lastname: Ostermann
authors.forename: D
authors.initials: D
authors.lastname: Melcher
authors.forename: R
authors.initials: R
authors.lastname: Schuster
authors.forename: C M
authors.initials: CM
authors.lastname: Erben
authors.forename: P F
authors.initials: PF
authors.lastname: Matthiessen
mesh_terms: D000293:Adolescent; D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology*; D000697:Central Nervous System Stimulants / Q000600:supply & distribution / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000706:statistics & numerical data*; D008297:Male; D008774:Methylphenidate / Q000600:supply & distribution* / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D012042:Registries / Q000706:statistics & numerical data*
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate